|
RGNX Regenxbio Inc 1590877 |
| Balance Sheet |
|
Current Assets
|
313,396,000 |
|
Assets
|
519,114,000 |
|
Current Liabilities
|
102,725,000 |
|
Liabilities
|
217,698,000 |
|
Equity
|
301,416,000 |
|
Shares Out
|
49,423,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-141,501,000 |
|
Investing Cash Flow
|
63,173,000 |
| Market Analysis |
Market Cap
|
644,231,274 |
|
Price
|
7.37 |
|
BVPS
|
6.10 |
|
PB
|
1.20 |
|
EPS
|
-5.27 |
|
PS
|
6.66 |
|
FCF
|
-78,328,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGNX documents filed with the SEC.
RGNX Filings
Clear
